NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. The company is headquartered in Emeryville, California and currently employs 70 full-time employees.
Novabay Pharmaceuticals stock last closed at $0.29, down 2.69% from the previous day, and has decreased 83.39% in one year. It has underperformed other stocks in the Biotechnology industry by 0.59 percentage points. Novabay Pharmaceuticals stock is currently +3.21% from its 52-week low of $0.28, and -89.14% from its 52-week high of $2.66.
There are currently 6.53M NBY shares outstanding. The market capitalization of NBY is $1.89M. In the past 24 hours, 111,893 NBY shares were traded.
You will need a brokerage account in order to access the NYSEMKT market and buy NBY shares.
Based on our research, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now.Open eToro Account
Now that you've picked the best brokerage, you'll need to fill out some personal details so you can invest in NBY today.
Now that you've finished signing up on investing apps, you need to deposit funds:
Watch the walkthrough below if you need help depositing money into your new brokerage account.
After you have figured out the best place to buy Novabay Pharmaceuticals stock, it's absolutely critical to research their stock prior to investing, so you truly understand the risk and upside.
WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on NBY's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NBY's true value.
Using relative valuations methods:
You can access additional valuation analysis on NBY's stock here.
Last year, NBY revenue was $14.64M. In the past 5 year, NBY's revenue has increased by -0.74% per year. This was slower than the Biotechnology industry average of 37.17%.
Learn more about NBY's earnings and revenue performance here.
Over the past 12 months, insiders at NBY have not bought or sold any shares.
Dig into more about who owns NBY stock here.
No, Novabay Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary order types:
Hit the Open Trade button and eToro will place your order.
If you require additional help with investing in stocks on eToro, click the how to video below:
Now that you own some shares in NBY, you'll want to stay up-to-date on your company.
Create a watchlist to keep track of your NBY stock.
To summarize, here are the 6 steps to buy stock in Novabay Pharmaceuticals:
If you are looking for a online brokerage, eToro is our favorite venue.Get Started with eToro Today
If you would like to get the latest scoop on your new investment in Novabay Pharmaceuticals, create a watchlist today.
How much does it cost to buy one Novabay Pharmaceuticals share?
What is the best way to buy Novabay Pharmaceuticals stock?